Antibody Discovery & Engineering
The Antibody Center at Curia provides end-to-end services in antibody discovery, engineering, and development.
Our process starts with listening to your project needs and then devising a customized scope of work for the delivery of your next panel of molecules. Whether you need an IgG, scFv, Fab, VHH, or multiple formats, our technical teams and leadership partner with you to help deliver the right molecules with the function, selectivity, and cross-reactivity that you need. Workflows for hybridoma, phage display, and yeast display technology platforms have been optimized for high-quality antibody discovery and are available for immunizations, panning and screening, cloning and sequencing, humanization, and affinity maturation.
Client Testimonial: Tri-Institutional Therapeutics Discovery Institute and LakePharma (now part of Curia): A Partnership in Antibody Discovery to Enable Innovative Therapeutics
Download a free eBook: Introduction to Hybridoma Technologies for Antibody Discovery
PentaMice™: A Unique Approach to Achieve Maximum Plasma Titers for Antibody Discovery webinar recording available NOW!
Discovery of Potent, Functional Anti-BTLA, and Anti-TIGIT Monoclonal Antibodies using Hybridoma and Phage Display Platform webinar recording available NOW.
Click here to download our Pentamice Flyer
Download the Antibody Discovery & Engineering Services Brochure here.
“LakePharma (now part of Curia) is nothing short of a true partner with Apollos Diagnostics. We will continue to work with Curia as a partner for all of our future antibody development campaigns.”
– John Alderete, Ph.D., MBA; Founder and President of Folium Biomed, LLC
View the testimonial here
“LakePharma (now part of Curia) is a great partner to work with. Their expertise enables them to generate large panels of antibodies that can be used as the foundation for our therapeutic candidates”
– Ronald Herbst, Ph.D., CSO, Pyxis Oncology
View Pyxis clinical pipeline
“LakePharma (now part of Curia) was a great partner; very helpful, focused, and committed. Thank you for your antibody engineering and production services which made this project a success.”
– Maria Day, ImmuNext
View their press release here